A patient-administered injection to treat hereditary transthyretin-mediated amyloidosis (ATTRv amyloidosis) has been recommended for routine NHS use in England. The National Institute for Health and ...
A new study from Cold Spring Harbor Laboratory Professor Nicholas Tonks, graduate student Yuxin Cen, and postdoctoral fellow ...
WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca and Alexion, AstraZeneca Rare Disease, will showcase 14 studies, including real-world evidence (RWE), from their portfolio and pipeline of ...
The life expectancy for transthyretin (ATTR) amyloidosis varies from person to person. Your age, overall health, and primary symptoms all play a role. Transthyretin amyloidosis (ATTR) is a rare ...
Healio spoke with Joban Vaishnav, MD, director of the Johns Hopkins Comprehensive Amyloidosis Center, about the process of diagnosing amyloidosis, the importance of multidisciplinary care in patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results